162 related articles for article (PubMed ID: 21118149)
1. Induction of chromosome malsegregation by nanomaterials.
Gonzalez L; Decordier I; Kirsch-Volders M
Biochem Soc Trans; 2010 Dec; 38(6):1691-7. PubMed ID: 21118149
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes.
Tavares AM; Louro H; Antunes S; Quarré S; Simar S; De Temmerman PJ; Verleysen E; Mast J; Jensen KA; Norppa H; Nesslany F; Silva MJ
Toxicol In Vitro; 2014 Feb; 28(1):60-9. PubMed ID: 23811260
[TBL] [Abstract][Full Text] [Related]
3. A high throughput in vitro analytical approach to screen for oxidative stress potential exerted by nanomaterials using a biologically relevant matrix: human blood serum.
Rogers EJ; Hsieh SF; Organti N; Schmidt D; Bello D
Toxicol In Vitro; 2008 Sep; 22(6):1639-47. PubMed ID: 18593597
[TBL] [Abstract][Full Text] [Related]
4. Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials.
Gonzalez L; Sanderson BJ; Kirsch-Volders M
Mutagenesis; 2011 Jan; 26(1):185-91. PubMed ID: 21164201
[TBL] [Abstract][Full Text] [Related]
5. Genotoxicity investigations on nanomaterials.
Oesch F; Landsiedel R
Arch Toxicol; 2012 Jul; 86(7):985-94. PubMed ID: 22456836
[TBL] [Abstract][Full Text] [Related]
6. Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application.
Nabeshi H; Yoshikawa T; Matsuyama K; Nakazato Y; Matsuo K; Arimori A; Isobe M; Tochigi S; Kondoh S; Hirai T; Akase T; Yamashita T; Yamashita K; Yoshida T; Nagano K; Abe Y; Yoshioka Y; Kamada H; Imazawa T; Itoh N; Nakagawa S; Mayumi T; Tsunoda S; Tsutsumi Y
Biomaterials; 2011 Apr; 32(11):2713-24. PubMed ID: 21262533
[TBL] [Abstract][Full Text] [Related]
7. Development of an in vitro screening method for safety evaluation of nanomaterials.
Matsuoka A; Onfelt A; Matsuda Y; Nakaoka R; Haishima Y; Yudasaka M; Iijima S; Tsuchiya T
Biomed Mater Eng; 2009; 19(1):19-27. PubMed ID: 19458442
[TBL] [Abstract][Full Text] [Related]
8. Induction of aneuploidy by single-walled carbon nanotubes.
Sargent LM; Shvedova AA; Hubbs AF; Salisbury JL; Benkovic SA; Kashon ML; Lowry DT; Murray AR; Kisin ER; Friend S; McKinstry KT; Battelli L; Reynolds SH
Environ Mol Mutagen; 2009 Oct; 50(8):708-17. PubMed ID: 19774611
[TBL] [Abstract][Full Text] [Related]
9. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
Hirose A; Nishimura T; Kanno J
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
[TBL] [Abstract][Full Text] [Related]
10. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
Warheit DB; Donner EM
Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
[TBL] [Abstract][Full Text] [Related]
11. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.
Johnston H; Brown D; Kermanizadeh A; Gubbins E; Stone V
J Control Release; 2012 Dec; 164(3):307-13. PubMed ID: 22940205
[TBL] [Abstract][Full Text] [Related]
12. In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test.
Balasubramanyam A; Sailaja N; Mahboob M; Rahman MF; Hussain SM; Grover P
Mutagenesis; 2009 May; 24(3):245-51. PubMed ID: 19237533
[TBL] [Abstract][Full Text] [Related]
13. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.
Murdock RC; Braydich-Stolle L; Schrand AM; Schlager JJ; Hussain SM
Toxicol Sci; 2008 Feb; 101(2):239-53. PubMed ID: 17872897
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of EB1 effects on microtubule dynamics.
Coquelle FM; Vitre B; Arnal I
Biochem Soc Trans; 2009 Oct; 37(Pt 5):997-1001. PubMed ID: 19754439
[TBL] [Abstract][Full Text] [Related]
15. Biomonitoring of genotoxic effects for human exposure to nanomaterials: The challenge ahead.
Gonzalez L; Kirsch-Volders M
Mutat Res Rev Mutat Res; 2016; 768():14-26. PubMed ID: 27234560
[TBL] [Abstract][Full Text] [Related]
16. Identification of tubulin drug binding sites and prediction of relative differences in binding affinities to tubulin isotypes using digital signal processing.
Chen K; Huzil JT; Freedman H; Ramachandran P; Antoniou A; Tuszynski JA; Kurgan L
J Mol Graph Model; 2008 Nov; 27(4):497-505. PubMed ID: 18951052
[TBL] [Abstract][Full Text] [Related]
17. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward.
Landsiedel R; Ma-Hock L; Haussmann HJ; van Ravenzwaay B; Kayser M; Wiench K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):399-413. PubMed ID: 22639437
[TBL] [Abstract][Full Text] [Related]
18. Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity.
Wang A; Marinakos SM; Badireddy AR; Powers CM; Houck KA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):430-48. PubMed ID: 23661551
[TBL] [Abstract][Full Text] [Related]
19. Nanotoxicity: a growing need for study in the endocrine system.
Lu X; Liu Y; Kong X; Lobie PE; Chen C; Zhu T
Small; 2013 May; 9(9-10):1654-71. PubMed ID: 23401134
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterial translocation--the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs--a review.
Kermanizadeh A; Balharry D; Wallin H; Loft S; Møller P
Crit Rev Toxicol; 2015; 45(10):837-72. PubMed ID: 26140391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
